In head and neck squamous cell carcinoma, the low expression of YTHDC2 correlated with lower overall survival (OS), recurrence-free survival, and reduced immune infiltration levels, suggesting its potential as a prognostic and immune infiltration marker for head and neck squamous cell carcinoma [67]. Here, YTHDC2 is linked to head and neck squamous cell carcinoma.